POSCO BIOVENTURES
POSCO BioVentures' primary investment focus is on companies with novel, proprietary bio-molecules. POSCO BioVentures expects that 70% of its investments will be in companies focused on novel proprietary bio-molecules, with the balance of the investments in other enabling technologies.
POSCO BIOVENTURES
Founded:
2002-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2011-01-03 | Accera | POSCO BioVentures investment in Series D - Accera | 11 M USD |
| 2010-03-30 | TransMedics | POSCO BioVentures investment in Series E - TransMedics | 36 M USD |
| 2010-03-08 | Pulmonx | POSCO BioVentures investment in Series C - Pulmonx | 32 M USD |
| 2008-11-12 | Accera | POSCO BioVentures investment in Series C - Accera | 35 M USD |
| 2007-04-13 | TransMedics | POSCO BioVentures investment in Series D - TransMedics | 25.5 M USD |
| 2006-03-14 | TransMedics | POSCO BioVentures investment in Series C - TransMedics | 29.75 M USD |
| 2006-01-01 | ProteinSimple | POSCO BioVentures investment in Series B - ProteinSimple | 27 M USD |
| 2005-01-18 | GeneOhm Sciences | POSCO BioVentures investment in Series C - GeneOhm Sciences | 14 M USD |
| 2004-09-16 | Accera | POSCO BioVentures investment in Series A - Accera | 6 M USD |
| 2004-06-23 | PTC Therapeutics | POSCO BioVentures investment in Series E - PTC Therapeutics | 15 M USD |